Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» lung cancer
lung cancer
Scrappy Upstarts Aiming For Pfizer's Xalkori Market
Seeking Alpha
Mon, 06/3/13 - 11:29 am
Pfizer
Xalkori
Tesaro
Ariad Pharmaceuticals
AP26113
lung cancer
TSR-011
Sanofi Ends Iniparib Research, Plans $285 Million Charge
Bloomberg
Mon, 06/3/13 - 10:37 am
iniparib
Sanofi
lung cancer
Synta's Lung Cancer Drug Struggles to Remain Relevant
TheStreet.com
Mon, 06/3/13 - 10:31 am
Synta Pharmaceuticals
lung cancer
ganetespib
Encouraging News for Peregrine Pharma
Yahoo/Zacks
Sat, 05/25/13 - 11:34 am
Peregrine Pharmaceuticals
bavituximab
non-small cell lung cancer
lung cancer
Bristol Myers Squibb And The New Wave Of Cancer Drugs
Seeking Alpha
Mon, 05/20/13 - 05:26 pm
Bristol-Myers Squibb
Merck
nivolumab
lambrolizumab
Roche
PD-L1
melanoma
cancer
lung cancer
Peregrine Pharma agrees with FDA on lung cancer trial design
Reuters
Mon, 05/20/13 - 11:42 am
FDA
Peregrine Pharmaceuticals
lung cancer
bavituximab
Merck KGaA Doesn’t Rule Out Pursuing Lung-Cancer Vaccine
Bloomberg
Fri, 05/17/13 - 11:31 am
Merck KGaA
vaccines
advanced lung cancer
lung cancer
L-BLP25
ASCO '13 Preview: Oncothyreon's Failed Lung Cancer Vaccine
TheStreet.com
Thu, 05/16/13 - 10:38 am
ASCO
lung cancer
vaccines
Oncothyreon
Stimuvax
Merck KGaA
Roche immunotherapy shows response over range of cancers
Reuters
Thu, 05/16/13 - 10:22 am
Roche
immunotherapy
MPDL3280A
melanoma
lung cancer
kidney cancer
Novartis Boost Seen in Fast Approvals as Protection Ends
Bloomberg
Mon, 05/6/13 - 09:08 am
drug approvals
Novartis
LDK378
lung cancer
Merrimack lung cancer drug fails goal in one mid-stage trial group
Reuters
Thu, 04/4/13 - 09:22 am
lung cancer
Merrimack Pharmaceuticals
MM-121
non-small cell lung cancer
Pfizer May Have To Rethink Xalkori Cost Structure
Seeking Alpha
Sat, 03/30/13 - 11:02 am
Pfizer
Xalkori
lung cancer
Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players
Motley Fool
Wed, 03/20/13 - 11:56 am
lung cancer
Roche
Avastin
Tarceva
Astellas
Pfizer
Xalkori
Celgene
Abraxane
Gemzar
Alimta
Eli Lilly
Qiagen seeks FDA sign-off for lung cancer companion Dx
FierceMedicalDevice
Tue, 01/15/13 - 11:11 pm
Qiagen
FDA
lung cancer
regulatory
devices
Analysis: Alimta patent seen as Lilly's "wild card"
Yahoo/Reuters
Fri, 01/4/13 - 10:05 am
Alimta
Eli Lilly
lung cancer
3 Things to Watch at Merrimack
Motley Fool
Sun, 12/30/12 - 12:12 pm
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
MM-121
breast cancer
lung cancer
Germany's Merck suffers setback with cancer drug
Yahoo/AP
Wed, 12/19/12 - 11:46 am
Merck KGaA
lung cancer
Stimuvax
Is Big Pharma Utilizing Too Many Resources on Potential Blockbusters?
Forbes
Wed, 11/7/12 - 12:35 pm
Xalkori
lung cancer
Pfizer
Varian Medical Systems Highlights a Comprehensive Product Portfolio for the Non-Invasive Treatment of Lung Cancer
Wed, 10/31/12 - 10:55 pm
Varian Medical
treatment
lung cancer
cancer
2 Biotech Stocks Ready To Flourish In The Wake Of Very Significant FDA News
Seeking Alpha
Sun, 10/14/12 - 11:02 am
Celgene
NPS Pharmaceuticals
lung cancer
Abraxane
Gattex
short bowel syndrome
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
…
next ›
last »